Comparar métodos

	Análisis de Variación del Número de Copias en Series Temporales	Llamada de variantes
Campo	Bioinformática	Bioinformática
Familia	Process / pipeline	Process / pipeline
Año de origen	2010s–present	2009–2010 (modern high-throughput era)
Autor original	Developed from foundational CNV methods (Olshen et al. 2004; Ding et al. 2010) extended to longitudinal tumor genomics frameworks	Li et al. (SAMtools/bcftools, 2009); McKenna et al. (GATK, 2010)
Tipo	Computational genomics pipeline	Computational genomics pipeline
Fuente seminal	Dentro, S. C., et al. (2021). Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell, 184(8), 2239-2254.	McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., ... & DePristo, M. A. (2010). The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research, 20(9), 1297–1303.
Alias	longitudinal CNV analysis, temporal copy number analysis, time-series CNV profiling, serial CNV analysis	SNP calling, genotyping from sequencing, mutation detection, variant detection
Relacionados	5	6
Resumen	Time-series copy number variation (CNV) analysis is a computational genomics pipeline that characterizes chromosomal gains and losses across multiple sequential samples from the same individual or tumor. By comparing copy number profiles at successive time points — such as diagnosis, mid-treatment, relapse — it reconstructs the clonal dynamics and evolutionary trajectories driving genome instability, enabling researchers to track how sub-populations expand, contract, or acquire new aberrations over time.	Variant calling is the computational process of identifying positions in a sequenced genome that differ from a reference sequence — including single nucleotide polymorphisms (SNPs), small insertions and deletions (indels), and structural variants. It transforms aligned sequencing reads into an interpretable catalogue of genetic differences, forming the foundation for population genetics, disease-gene discovery, and clinical genomics applications.